title: From DNA binding to metabolic control: integration of -omics data reveals drug targets for prostate cancer.
authors: Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
authors: Hui
authors: H
authors: Gao
authors: Karin
authors: K
authors: Dahlman-Wright
mesh_terms: D000970:Antineoplastic Agents / Q000302:isolation & purification / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D045744:Cell Line, Tumor; D004247:DNA / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism; D003627:Data Interpretation, Statistical; D055808:Drug Discovery / Q000379:methods*; D023281:Genomics / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008660:Metabolism / Q000235:genetics* / Q000502:physiology; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011485:Protein Binding / Q000502:physiology; D040901:Proteomics / Q000379:methods / Q000706:statistics & numerical data; D011944:Receptors, Androgen / Q000378:metabolism / Q000502:physiology; D018511:Systems Integration
chemical_list: D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D011944:Receptors, Androgen; D004247:DNA